Growth Metrics

Merck (MRK) Enterprise Value Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 3.89%
Dec 31, 2025 -12.75%
Sep 30, 2025 -20.08%
Jun 30, 2025 4.91%
Mar 31, 2025 -4.55%
Dec 31, 2024 -5.65%
Sep 30, 2024 -12.88%
Jun 30, 2024 -10.02%
Mar 31, 2024 8.50%
Dec 31, 2023 4.11%
Sep 30, 2023 2.80%
Jun 30, 2023 2.97%
Mar 31, 2023 -7.72%
Dec 31, 2022 -9.69%
Sep 30, 2022 6.97%
Jun 30, 2022 6.16%
Mar 31, 2022 9.24%
Dec 31, 2021 10.69%
Sep 30, 2021 5.00%
Jun 30, 2021 6.30%
Mar 31, 2021 11.72%
Dec 31, 2020 9.80%
Sep 30, 2020 9.53%
Jun 30, 2020 0.32%
Mar 31, 2020 13.84%
Dec 31, 2019 7.84%
Sep 30, 2019 11.01%
Jun 30, 2019 11.96%
Mar 31, 2019 13.53%
Dec 31, 2018 10.27%
Sep 30, 2018 8.40%
Jun 30, 2018 13.84%
Mar 31, 2018 11.39%
Dec 31, 2017 9.61%
Sep 30, 2017 1.56%
Jun 30, 2017 1.59%
Mar 31, 2017 -1.87%
Dec 31, 2016 -2.39%
Sep 30, 2016 -1.10%
Jun 30, 2016 -0.33%
Mar 31, 2016 -3.97%
Dec 31, 2015 -6.42%
Sep 30, 2015 -7.99%
Jun 30, 2015 -8.29%
Mar 31, 2015 -16.14%
Dec 31, 2014 -16.76%
Sep 30, 2014 8.62%
Jun 30, 2014 0.93%
Mar 31, 2014 -24.40%